National Overview
Hyperbaric Medicine in Canada — By the Numbers
A snapshot of Canada's hyperbaric infrastructure, treatment capacity, and market position within the global landscape.
25+
Hospital-Based Facilities
Across 7 provinces
200+
Clinical-Grade Chambers
Monoplace & multiplace
14+
UHMS-Approved Indications
Evidence-based conditions
7%
Annual Market Growth
CAGR — global HBOT market
Facilities by Province
Global Market Context
$3–4B USD
Global HBOT market valuation (2024 estimates)
50,000–150,000
Estimated annual HBOT treatments in Canada
Growth is primarily driven by the private clinic sector, increased interest in neurological applications (TBI/concussion), long COVID research, and an aging population with rising diabetes prevalence.
Data compiled from UHMS, Health Canada, Grand View Research, and Fortune Business Insights. Facility counts are estimates — Canada does not maintain a centralized hyperbaric registry.